Derieux, Cécile
Léauté, Audrey
Brugoux, Agathe
Jaccaz, Déborah
Terrier, Claire
Pin, Jean-Philippe http://orcid.org/0000-0002-1423-345X
Kniazeff, Julie
Le Merrer, Julie
Becker, Jerome A. J.
Funding for this research was provided by:
EC | European Regional Development Fund
C-Valo, Inserm Transfert (CoPOC), Région Centre (ARD2020 Biomédicament – GPCRAb, Cisbio Bioassays, Perkin Elmer
ERA-NET NEURON (Magnolia project), C-Valo, Inserm Transfert (CoPOC), Région Centre
Article History
Received: 8 October 2021
Revised: 7 March 2022
Accepted: 21 March 2022
First Online: 13 April 2022
Competing interests
: JLM and JAJB are co-inventors of the patent WO2018096184: “Use of bromides in the treatment of autistic spectrum disorder”, US Patent App. 16/464,403, 2021 and patent application EP 21 194 699: “Methods for treating autism spectrum disorders”. CD, AL, AB, DJ, CT, JPP, and JK report no biomedical financial interests or potential conflicts of interest.